Project Overview

CSL Seqirus, the world's second largest influenza vaccine provider announced plans to construct a new world-class biotech manufacturing facility in Melbourne, Australia to supply influenza vaccines to Australia and the rest of the world, plus Australian antivenoms and Q-Fever vaccine. CSL Seqirus is a wholly owned subsidiary of CSL Limited, which will invest more than AUD$800 million in capital expenditure to construct the facility.

The building is expected to be operational by mid-2026.The state-of-the-art facility will use innovative cell-based technology to produce influenza vaccines for use in both influenza pandemics and seasonal vaccination programs - and will be the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere. The facility will also manufacture CSL Seqirus' proprietary adjuvant MF59R - a substance added to some vaccines to help improve immune response and to reduce the amount of antigen needed for each vaccine, enabling more doses to be manufactured more rapidly in a pandemic situation. In addition, the facility will produce unique products important to Australia's public health needs - including antivenom for Australian snakes, spiders and marine creatures, and the world's only human vaccine for Q-Fever.

General Description of Progress by February 2024

• Certificate of Occupancy achieved for Administration facility
• All structural works for all the PNS and FCC facilities complete
• Fit out of PNS and FCC facilities practically compete
• Commissioning well advanced
• Certificate of Occupancy for the site targeted end of April 2024
• Commissioning completion targeted for July 2024
• Qualification completion targeted for December 2024

Key Categories to be Supported:

Our Procurement team supports a number of different categories to ensure Project Objectives are achieved and to identify supplier capabilities to support operations of the facility when functional. Below is the indicative list of categories that is of interest to the project.

Operations Phase

Direct Spend

• Raw Materials and Packaging
• Buffers, Media and Solutions

Indirect Spend

• Building maintenance
• Security
• Waste Disposal Services
• Cleaning Services
• IT (Hardware, Software and Digital Technology)
• (Maintenance, Repair & Operations) MRO Services and Supply
• Professional Services (Labour Hire and Business Consultancy)
• Warehousing and Logistic service provider
• Office supplies
• Facilities Management
• Building Automation
• Trades (Example: Electrical, Plumbing, Fabrication)

Vendor Accreditation Process

The purpose of the Vendor Accreditation Process (VAP) is to assess and pre-qualify vendors to supply equipment, perform work or provide services for CSL at all Seqirus project site.

Key objectives of the VAP are to:

• Define a harmonized global process for the assessment and approval of vendors supplying equipment, performing work or providing services to all CSL Behring manufacturing sites.
• Define the boundaries and responsibilities of Category Leads in the global sourcing team.
• Establish and maintain a databank of all Vendor assessments and approval status for all CSL entities.
• Introduce a review cycle for all suppliers in order to accommodate the changing market environment.
• Define a method of recourse for disputes.
• List the evaluation criteria and templates.

The assessment consists of the following seven independent sections performed independent of each other:

1. Legal Compliance
2. Quality (QA/QC)
3. Engineering and R&D (Technical)
4. Financial
5. HS&E
6. Supply Chain Integrity
7. Trade compliance

Industry Briefing

Click here to watch the Project Banksia Industry Briefing recording.

HOW TO REGISTER AN EXPRESSION OF INTEREST (EOI)

• Work Packages currently available to submit an EOI for are listed below.
• To submit an initial EOI for the Work Package listed, companies must have an ICN Gateway company profile. Information on how to register your company on ICN Gateway is detailed below.
• This is an initial, generic EOI submission only. All companies who submit an EOI will be included in information presented to the project owner for this project.
• The project owner will be provided with your detailed company profile outlining capabilities to supply into the project. The project owner will contact you directly if you are shortlisted to tender or quote.
• The services, programmes and initiatives provided by ICN Victoria are aimed at complimenting a company's existing Sales, Marketing and Business Development strategy and any EOI submitted should not be considered as an alternative to these activities.
  

ICN GATEWAY COMPANY REGISTRATION

• Click here to register your company profile on ICN Gateway.
• Support and assistance is available through the web links listed below.
• An ICN Gateway company profile that accurately and effectively summarises your company is critical to using the services of the ICN Group - please ensure that your company invests the time and energy required to represent your company in the most effective manner possible.
• Companies should ensure that the email Notification functionality within their ICN Gateway company profile is activated to include an appropriate level of coverage to Major Projects and Regional Opportunities.
  

(1) ICN Gateway Setup Wizard

(2) ICN Gateway User Guide